Skip to main content
. 2024 Jul 27;25(15):8226. doi: 10.3390/ijms25158226
β-PEA β-phenylethylamine
T1AM 3-iodothyronamine
TMA trimethylamine
CHA cyclohexylammonium ion
METH methamphetamine
AMPH amphetamine
(Q)SAR (quantitative) structure-activity relationship
HM homology model
VS virtual screening
HTS high throughput screening
ROC-AUC (receiver operating characteristic-area under the curve)
RMSD root mean square deviation
AF AlphaFold
β2-ADR β2-adrenoreceptor
5-HT6R 5-hydroxytryptamine receptor 6
5-HT2AR 5-hydroxytryptamine receptor 2A
5-HT2BR 5-hydroxytryptamine receptor 2B
M3R muscarinic acetylcholine receptor
D1R dopamine D1 receptor
α1A-ADR α1A-adrenergic receptor
α1B-ADR α 1B-adrenergic receptor
α2A-ADR α2A-adrenergic receptor
H2R hystidine receptor type 2
SEP-363856 ulotaront
RO-6889450 ralmitaront